Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Biobank Clinical Genetics Maastricht (KG01) (KG01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02266615
Recruitment Status : Recruiting
First Posted : October 17, 2014
Last Update Posted : August 21, 2019
Sponsor:
Information provided by (Responsible Party):
Maastricht University Medical Center

Brief Summary:
Collection of coded biomaterial and clinical data with patients consent for future research.

Condition or disease Intervention/treatment
Genetic Disease Genetic: Biobanking of biomaterial for future genetic research.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 3600 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Biobank Clinical Genetics Maastricht
Study Start Date : September 2014
Actual Primary Completion Date : March 2018
Estimated Study Completion Date : September 2034

Group/Cohort Intervention/treatment
Genetic research in 5 areas.
Cardiogenetics; Intellectual Disability, Multiple Congenital Abnormalities and Rare Diseases; Oncogenetics; Dermatogenetics; Reproductive Genetics.
Genetic: Biobanking of biomaterial for future genetic research.



Primary Outcome Measures :
  1. Comparing genes to discover unknown functions [ Time Frame: Genes will be sequenced and compared, within an expected average of 6 months. ]
    The biobanked bio material and medical data can be used for future research to learn more about the function of genes.


Biospecimen Retention:   Samples With DNA
DNA retrieved out of blood or tissue


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital and who get blood or tissue sampled for DNA diagnostics.
Criteria

Inclusion Criteria:

  • New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital
  • Withdrawal of body material for genetic diagnostics.

Exclusion Criteria:

  • Patient does not understand the Dutch language.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02266615


Contacts
Layout table for location contacts
Contact: I. Krapels, MD, PhD +31433875880 ingrid.krapels@mumc.nl

Locations
Layout table for location information
Netherlands
Maastricht University Medical Center Recruiting
Maastricht, Limburg, Netherlands, 6229 HV
Contact: M. Eijck-Vievermans    +313876447    margo.vievermans@mumc.nl   
Sponsors and Collaborators
Maastricht University Medical Center

Layout table for additonal information
Responsible Party: Maastricht University Medical Center
ClinicalTrials.gov Identifier: NCT02266615     History of Changes
Other Study ID Numbers: METC-14-4-077
First Posted: October 17, 2014    Key Record Dates
Last Update Posted: August 21, 2019
Last Verified: August 2019
Additional relevant MeSH terms:
Layout table for MeSH terms
Genetic Diseases, Inborn